ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

ASN / Education & Meetings / Kidney Week /

Translational Session

APOL1-Mediated Kidney Disease: Year in Review, Including the Michelle P. Winn, MD, Endowed Lectureship

October 25, 2024 | 02:00 PM - 04:00 PM

Location: Ballroom 20D, Convention Center

Session Description

More than 10 years ago, variants in the APOL1 gene were identified as a major genetic risk factor for CKD in persons of African ancestry. This session reviews the epidemiology of APOL1-mediated kidney disease (AMKD), the effects of genetic variants on disease progression in native and transplanted kidneys, identification of disease modifiers, and pharmacologic and nonpharmacologic strategies to slow the rate of disease progression.

ASN gratefully acknowledges Duke University School of Medicine, the school's Division of Nephrology, and several individuals for support of the Winn Endowed Lectureship.

Learning Objective(s)

  • Explain the relationship between proteinuria and disease progression in AMKD
  • Discuss genetic and environmental disease modifiers for AMKD
  • Describe effects of nutrition on disease progression in AMKD
  • Identify new therapeutic targets for AMKD

Learning Pathway(s)

  • Genetic Diseases and Development
  • Glomerular Diseases

Moderators

Presentations